Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2144/btn-2020-0096 http://scihub22266oqcxt.onion/10.2144/btn-2020-0096 33161729!7651990!33161729     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Biotechniques 2021 ; 70 (1): 58-67 Nephropedia Template TP {{tp|p=33161729|t=2021. Evidence-based point-of-care technology development during the COVID-19 pandemic |pdf=|usr=}}{{33161729}} gab.com Text Evidence-based point-of-care technology development during the COVID-19 pandemic JO: Biotechniques http://www.kidney.de/pget.php?&tw=1&pmid=33161729 #FOAvip Since December 2019, the SARS-CoV-2 outbreak that began in Wuhan, China has spread to nearly every continent and become a global health concern. Although much has been discovered about COVID-19 and its pathogenesis, the WHO has identified an immediate need to increase the levels of testing for COVID-19 and identify the stages of the disease accurately for appropriate action to be taken by clinicians and emergency care units. Harnessing technology for accurate diagnosis and staging will improve patient outcomes and minimize serious consequences of false-positive test results. Point-of-care technologies aim to intervene at every stage of the disease to quickly identify infected patients and asymptomatic carriers and stratify them for timely treatment. This requires the tests to be rapid, accurate, sensitive, simple to use and compatible with many body fluids. Mobile platforms are optimal for remote, small-scale deployment, whereas facility-based platforms at hospital centers and laboratory settings offer higher throughput. Here we review evidence-based point-of-care technologies in the context of the entire continuum of COVID-19, from early screening to treatment, and discuss their impact on improving patient outcomes. Twit Text FOAVip Evidence-based point-of-care technology development during the COVID-19 pandemic ????Biotechniques http://www.kidney.de/pget.php?&tw=1&pmid=33161729 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33161729 #FOAvip English Wikipedia <ref>{{Cite pmid|33161729}}</ref> Evidence-based point-of-care technology development during the COVID-19 pandemic #MMPMID33161729 Parupudi T; Panchagnula N; Muthukumar S; Prasad S Biotechniques 2021[Jan]; 70 (1): 58-67 PMID33161729show ga Since December 2019, the SARS-CoV-2 outbreak that began in Wuhan, China has spread to nearly every continent and become a global health concern. Although much has been discovered about COVID-19 and its pathogenesis, the WHO has identified an immediate need to increase the levels of testing for COVID-19 and identify the stages of the disease accurately for appropriate action to be taken by clinicians and emergency care units. Harnessing technology for accurate diagnosis and staging will improve patient outcomes and minimize serious consequences of false-positive test results. Point-of-care technologies aim to intervene at every stage of the disease to quickly identify infected patients and asymptomatic carriers and stratify them for timely treatment. This requires the tests to be rapid, accurate, sensitive, simple to use and compatible with many body fluids. Mobile platforms are optimal for remote, small-scale deployment, whereas facility-based platforms at hospital centers and laboratory settings offer higher throughput. Here we review evidence-based point-of-care technologies in the context of the entire continuum of COVID-19, from early screening to treatment, and discuss their impact on improving patient outcomes. |*COVID-19[MESH] |*Pandemics[MESH] |*Point-of-Care Systems[MESH] |COVID-19 Testing/*instrumentation[MESH] |Disease Progression[MESH] |Humans[MESH]Evidence-based point-of-care technology development during the COVID-1(epmc).pdf DeepDyve Pubget Overpricing